CEO of SpineMatrix. "Not only are we improving patient care, but we're providing a tool with the real potential to save millions of dollars for consumers, employers and health plans."
The Lumbar Matrix Scan collects thousands of bioelectrical signals from the back and reconstructs them into easily interpreted images, which helps physicians to differentially diagnose lower back pain by identifying disc, facet and muscle pathology.
The FDA-approved procedure monitors and displays the bioelectric signals produced by the paraspinal neuromuscular system using an array of 63 sensors that are placed on the back. The sensors are connected to a computer, which is calibrated to read the neuromuscular activity covered by the electrode grid.
Typically, the scan is used to capture three lower back scans of the patient in varying stances:
- Standing relaxed with arms at side (baseline)
- Flexing at the hips to a 20-degree angle
- Standing with arms outstretched in front holding a three-pound weight in each hand
The image of the bioelectric signals produced by the low back muscles indicates the precise origin of low back pain. The procedure is fast, taking less than 15 minutes, and costs much less than an MRI, CT scan or invasive procedures. Factor in the savings on unnecessary treatments to relieve the pain, and the positive impact on healthcare costs significantly increases.
In blinded clinical studies at the Cleveland Clinic, Texas Back Institute and The Ohio State University College of Medicine, the Lumbar Matrix Scan was shown to be a safe, non-invasive and effective diagnostic procedure.
"Patients are already benefiting from the Lumbar Matrix Scan's ability to more accurately identify the source of low back pain," said Shappley. "But many individuals continue to suffer from iPage: 1 2 3 Related biology technology :1
. RSB Spine, LLC Announces First Implantation of the InterPlate(TM) L for the Lumbar Spine2
. Siemens New S Class Revolutionizes the Paradigm of Ultrasound Workflow Today and Tomorrow3
. A New Era in the Application of Lab-on-a-Chip to Rapid Point-of-Care Diagnosis4
. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Germany & Austria5
. Transforming medical diagnosis with new scanning technology6
. Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease7
. International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"8
. In 2008, Ipsogen Reinforced its Leadership in Molecular Diagnosis and Monitoring of Leukemia9
. deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke10
. SpectraScience Awarded Patent for Its Optical Biopsy System and Methods for Tissue Diagnosis11
. University of Southern California Receives Cancer Diagnosis System for Detecting Esophageal Dysplasia